Literature DB >> 9516864

The International Neuroblastoma Risk Groups (INRG): a preliminary report.

R P Castleberry1, J Pritchard, P Ambros, F Berthold, G M Brodeur, V Castel, S L Cohn, B De Bernardi, C Dicks-Mireaux, D Frappaz, G M Haase, M Haber, D R Jones, V V Joshi, M Kaneko, J T Kemshead, P Kogner, R E Lee, K K Matthay, J M Michon, R Monclair, B R Roald, R C Seeger, P J Shaw, J J Shuster.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9516864     DOI： 10.1016/s0959-8049(97)00202-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  27 in total

Review 1.  Neuroblastoma.

Authors:  S Shah; Y Ravindranath
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

Review 2.  Cellular kinetics of neuroblastoma and the role of surgery.

Authors:  Tatsuo Kuroda
Journal:  Pediatr Surg Int       Date:  2011-07-19       Impact factor: 1.827

3.  Differential expression of minimal residual disease markers in peripheral blood and bone marrow samples from high-risk neuroblastoma patients.

Authors:  Nobuyuki Yamamoto; Aiko Kozaki; Tri Budi Hartomo; Tomoko Yanai; Daiichiro Hasegawa; Keiichiro Kawasaki; Yoshiyuki Kosaka; Masafumi Matsuo; Satoshi Hirase; Takeshi Mori; Akira Hayakawa; Kazumoto Iijima; Hisahide Nishio; Noriyuki Nishimura
Journal:  Oncol Lett       Date:  2015-09-16       Impact factor: 2.967

4.  The Potential Contribution of microRNAs in Anti-cancer Effects of Aurora Kinase Inhibitor (AZD1152-HQPA).

Authors:  Ali Zekri; Yashar Mesbahi; Elham Boustanipour; Zahra Sadr; Seyed H Ghaffari
Journal:  J Mol Neurosci       Date:  2018-07-26       Impact factor: 3.444

5.  High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.

Authors:  Wolfgang Peter Fendler; Henriette Ingrid Melzer; Christoph Walz; Dietrich von Schweinitz; Eva Coppenrath; Irene Schmid; Peter Bartenstein; Thomas Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-07-16       Impact factor: 9.236

Review 6.  The connections between neural crest development and neuroblastoma.

Authors:  Manrong Jiang; Jennifer Stanke; Jill M Lahti
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

7.  A rare case of primary omental neuroblastoma and resection of the recurrent tumor by laparoscopy.

Authors:  Kin Wai Edwin Chan; K H Lee; K F To; J W C Mou; S T Cheung; Y H Tam
Journal:  Pediatr Surg Int       Date:  2008-12-05       Impact factor: 1.827

8.  Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells.

Authors:  Haiyan Liu; Xianrang Song; Chunxi Liu; Li Xie; Ling Wei; Ruopeng Sun
Journal:  J Exp Clin Cancer Res       Date:  2009-02-15

9.  Early detection of tumor relapse/regrowth by consecutive minimal residual disease monitoring in high-risk neuroblastoma patients.

Authors:  Satoshi Hirase; Atsuro Saitoh; Tri Budi Hartomo; Aiko Kozaki; Tomoko Yanai; Daiichiro Hasegawa; Keiichiro Kawasaki; Yoshiyuki Kosaka; Masafumi Matsuo; Nobuyuki Yamamoto; Takeshi Mori; Akira Hayakawa; Kazumoto Iijima; Hisahide Nishio; Noriyuki Nishimura
Journal:  Oncol Lett       Date:  2016-06-07       Impact factor: 2.967

10.  Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.

Authors:  Rochelle Bagatell; Maja Beck-Popovic; Wendy B London; Yang Zhang; Andrew D J Pearson; Katherine K Matthay; Tom Monclair; Peter F Ambros; Susan L Cohn
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.